Figure 2 - uploaded by Christopher Wolff
Content may be subject to copyright.
The relative volumes of arteries and veins, considered as percentages of total blood volume, constitute a total of around 72% (10). Arteries constitute 12% and veins 60% of total vascular capacity. (Elsewhere venous volume is said to constitute 70% (14). 

The relative volumes of arteries and veins, considered as percentages of total blood volume, constitute a total of around 72% (10). Arteries constitute 12% and veins 60% of total vascular capacity. (Elsewhere venous volume is said to constitute 70% (14). 

Source publication
Article
Full-text available
This paper discusses two kinds of regulation essential to the circulatory system: namely the regulation of blood flow and that of (systemic) arterial blood pressure. It is pointed out that blood flow requirements sub-serve the nutritional needs of the tissues, adequately catered for by keeping blood flow sufficient for the individual oxygen needs....

Context in source publication

Context 1
... return) amounts to total tissue blood flow and as the heart puts out what it receives cardiac output is therefore determined at the tissues. Hence, regulation of arterial blood pressure is independent of the distributed independent regulation of individual tissues. It is proposed here that mechanical features of arterial blood pressure regulation will depend rather on the balance between blood volume and venous wall tension, determinants of venous pressure. The potential for this explanation is treated in some detail. Blood flow regulation is subordinate to the oxygen requirements of individual tissues. For the majority of individual tissues the rate of oxygen delivery (DO 2 ) is normally sustained at a specific, individual, ratio relationship to oxygen consumption (VO 2 ) (1-4). For skeletal muscle the ratio is close to 1.5, for brain 3 and heart 1.6. These ratios are sustained over a moderate physiological range of metabolic rate changes by proportional changes in blood flow. Where arterial oxygen content (CaO 2 ) is reduced, blood flow increases such that the DO 2 to VO 2 ratio is sustained. For example, for moderate levels of activity, normal skeletal muscle oxygen delivery (1.5 times VO 2 ) is sustained in the face of reduced oxygen content (CaO 2 , either anaemia, hypoxia or both combined), down to levels only 60% of normal CaO 2 (5). Compensation for low CaO 2 is also sustained for the cardiac blood supply down to 60% of normal CaO 2 (3) whereas, for the brain, the lower limit for CaO 2 is around 90% of normal (6). The regulation of blood flow, sustaining appropriate rates of oxygen delivery, resides at the tissues. Blood flow regulation at the tissues has been shown to be independent of the nervous system (2). Guyton’s group showed that there is the same ‘correlation between local blood flow and arterial oxygen saturation in animals under total spinal anesthesia as seen in normal animals’ (7,8). An example of the determination of cardiac output and oxygen delivery by the metabolic requirements of tissues is found in the study of exercise by Donald and Shepherd (9); illustrated in Figure 1. Here the tissue demand from exercise is met, whether or not cardiac innervation is present. The difference is that there is a much larger stroke volume for the denervated heart, since the heart rate fails to increase normally. Since there is independent control of blood flow at the tissues, the idea that sympathetic vaso-constrictor nerves are the principal regulator of blood flow by acting on the arterioles or on myocardial contractility (10,11) requires revision. There is a related problem in view of known arteriolar constriction which occurs with stimulation of the sympathetic nerve supply to arterioles. The main problem, however, is the need for hypotheses addressing means by which blood pressure regulation occurs independently of the regulation of blood flow. A wealth of evidence attests to the role of the autonomic nervous system, especially the sympathetic division, in the regulation of arterial blood pressure (11). There is the well-known short-term regulation, via afferent information from the arterial baro-receptors, with brain stem processing and both parasympathetic and sympathetic efferent output. Where arterial blood pressure rises, or the arterial baro- receptor mechanism is stimulated by some other means, the inhibitory response results in reflex lowering of arterial pressure. There is also the longer term renal mediation, partly via sympathetic efferent innervation, with additional humoral involvement. The renal involvement affects blood volume, which in turn affects arterial blood pressure (12). There are also effects mediated by volume receptors on the venous side of the circulation. There is a mass of detail available in the literature concerning, in particular, central connections involving major sites, such as the nucleus of the tractus solitarius (NTS), the rostral ventro-lateral medulla (RVLM) and the hypothalamus (11). It is known that there is sympathetic innervation of the arterioles, causing the theoretical difficulty mentioned above, since the resistance offered by arterioles is adjusted precisely such that DO bears the correct relationship to VO . This problem will be considered later. A second known innervation is of the peripheral veins, where sympathetic stimulation raises venous pressure (11,13). Furthermore, “small veins and venules are more sensitive to sympathetic activation than arterioles” (14,15). The role of changes in venous pressure will be discussed in relation to means by which arterial blood pressure may be regulated independently of blood flow changes. (i) Altered venous capacity The dominant role of peripheral venous pressure in determining arterial BP is discussed in Guyton et al. (2). In relation to the interdependence of arteries and veins it is worth considering the relative volumes of the whole arterial tree and that of both the venous and arterial systems. Figure 2 illustrates the approximately five- to six-fold difference in venous and arterial volumes. Assuming the venous system volume is five times the arterial volume, knowing the venous and arterial percentages, we can calculate the effect of small changes in venous volume. Starting with the idea of a total blood volume of 5 litres, the arterial volume, at 12%, is 600 ml, whereas the venous volume, at 60%, will be 3000 ml. If we reduce the venous volume by 150 ml, and this is transferred into the arteries, it will have increased arterial volume by 25% (to 750 ml) and thus arterial blood pressure might be expected to increase by more than 25% since arterial compliance decreases as its volume increases. The initial action, reducing venous volume, would require reduction of venous wall compliance (or increase in wall tension or ‘tone’). Hottenstein and Kreulen (15) emphasize the particular role of the sympathetic activation here. Although this is a very simple model it shows how we would expect a small change in venous volume to generate a large change in arterial blood pressure. (ii) Altered blood volume If the venous wall initial ‘tone’ remains unaltered but blood volume increases, for whatever reason, this will stretch the vein walls and the pressure on the venous side of the circulation will increase. This will also cause a re-distribution, with a sharing of the extra volume between arteries and veins, according to their relative compliance. While mean arterial compliance is much lower than venous any extra fluid will raise arterial pressure. It is known that there is sympathetic innervation of both arteriolar and peripheral venous wall smooth muscle and, as pointed out above, this raises the question as to how the tissues sustain precisely appropriate blood flows in the face of alterations in sympathetic drive to arterioles. It is possible that, under particular circumstances, there is local modulation of arteriolar and venous tone, such that the tissue concerned still achieves the appropriate input resistance. Overall sympathetically mediated increases in arteriolar tone could be compatible with facilitating appropriate blood flow in individual tissues, under conditions of altered systemic arterial blood pressure. In other words the sympathetic efferent input/output reflex may well function specifically at locations where the situation changes, such as in the leg vasculature with postural change (such as standing up from the sitting position). Postural change alters the head of pressure (16). A second example is the classic effect of the Valsalva maneuver in normal subjects. Here, blood flow is strongly opposed by the raised intra-thoracic pressure since arterial blood pressure falls to low levels. Recovery of blood flow is assumed to result from the restoration of systemic arterial blood pressure towards the end of the maneuver. This is attributed to the well documented sympathetically driven increase in tone in splanchnic and renal veins, with restoration of arterial blood pressure. Recent unpublished work shows that blood flow is also restored as arterial blood pressure recovers in the late stage of the Valsalva manoeuver. Hence we have the possibility that changes in arteriolar resistance mediated by sympathetic innervation can be over-ridden by the tissue concerned and that situations can occur where tissue blood flow control is facilitated. During exercise venous tone is presumably greater than at rest, avoiding dilatation from the increased blood flow. This area remains open to further discussion and investigation. One of the situations where abnormal blood volume re-distribution occurs is with the induction of anaesthesia. There is known reduction of sympathetic outflow (17,18,19) and cardiac output and arterial blood pressure fall together. This is a situation where the fall in arterial blood pressure is entirely due to relaxation of the venous system walls, since there has been no change in blood volume. The relaxed venous system having a larger capacitance (with increased compliance/reduced tone) results in a redistribution of the blood volume. The small loss of arterial volume will have a disproportionate effect in lowering the arterial blood pressure. It also means that the tissue requirement becomes deficient with artificial reduction of cardiac output (slower arrival of tissue output at the heart, and less blood in the arterial system to sustain perfusion). Abnormal blood volume distribution is also recognised in the setting of arteriovenous (AV) fistulae or large AV malformations and is associated with reduction in arterial blood pressure. Here the primary mechanism is the reduction in total systemic vascular resistance resulting in a modicum of arterial blood loss to the veins increasing venous volume, rather than any change in venous wall tone. Here cardiac output is increased. This finding has been exploited to therapeutic benefit in a novel technology to treat hypertension: the ...

Similar publications

Article
Full-text available
Background: Children on extracorporeal devices are at increased risk of hypothermia and require circuits with lower extracorporeal volume (ECV) to avoid blood priming. We performed an in vitro study of the enFlow™ (Vyaire medical, Mettawa, IL) blood warmer to assess its warming performance and impact on circuit resistance at a high blood flow rate...

Citations

... Sepsis patients can develop tissue and organ hypoperfusion early and progress rapidly to multi-organ failure. MAP is a widelyused parameter indicating the driving force of tissue and organ perfusion pressure, and appropriate MAP is prerequisite for adequate perfusion of major organs, so MAP has always been of more concern among critical care researchers [26,27]. At the same time, it is the only pressure indicator that has been constantly mentioned and recommended in successive international guidelines for the management of sepsis and septic shock [13,[28][29][30][31][32], which highlights its clinical importance. ...
Article
Full-text available
Background: Sepsis is a life-threatening organ dysfunction caused by the infection-related host response disorder. Adequate mean arterial pressure is an important prerequisite of tissue and organ perfusion, which runs through the treatment of sepsis patients, and an appropriate mean arterial pressure titration in the early-stage correlates to the positive outcome of the treatment. Therefore, in the present study, we aimed to elucidate the relationship between early mean arterial pressure levels and short-term mortality in sepsis patients. Methods: We included all suspected sepsis patients from MIMIC-III database with average mean arterial pressure ≥ 60 mmHg on the first day of intensive care unit stay. Those patients were then divided into a permissive low-mean arterial pressure group (60-65 mmHg) and a high-mean arterial pressure group (> 65 mmHg). Multivariate Cox regression analysis was conducted to analyze the relationship between MAP level and 30-day, 60-day, and 100-day mortality of suspected sepsis patients in the two groups. Propensity score matching, inverse probability of treatment weighing, standardized mortality ratio weighting, PA weighting, overlap weighting, and doubly robust analysis were used to verify our results. Results: A total of 14,031 suspected sepsis patients were eligible for inclusion in our study, among which 1305 (9.3%) had an average first-day mean arterial pressure of 60-65 mmHg, and the remaining 12,726 patients had an average first-day mean arterial pressure of more than 65 mmHg. The risk of 30-day mortality was reduced in the high mean arterial pressure group compared with the permissive low-mean arterial pressure group (HR 0.67 (95% CI 0.60-0.75; p < 0.001)). The higher mean arterial pressure was also associated with lower 60-day and 100-day in-hospital mortality as well as with shorter duration of intensive care unit stay. Patients in the high-mean arterial pressure group also had more urine output on the first and second days of intensive care unit admission. Conclusions: After risk adjustment, the initial mean arterial pressure of above 65 mmHg was associated with reduced short-term mortality, shorter intensive care unit stay, and higher urine volume in the first two days among patients with sepsis.
... Numerous large studies (18)(19)(20) have been conducted over the past decade comparing the relationship between different pressure indicators and the prognosis of patients with sepsis, such as central venous pressure, pulmonary capillary wedge pressure, and MAP. Since MAP is not only a determinant of mean circulatory filling pressure but also a major driver of venous return and cardiac output, research into the relationship between MAP and the prognosis of patients with sepsis has been favored by scholars (21,22). At the same time, the mean arterial pressure is also the focus of successive international guidelines for the management of sepsis and septic shock (11,(23)(24)(25)(26)(27). ...
Article
Full-text available
Background: Sepsis is a life-threatening organ dysfunction due to disturbance of the host's response to infection, and is often accompanied by shock. Timely and standardized hemodynamic management can effectively control disease progression. Mean arterial pressure (MAP) refers to tissue and organ perfusion and is one of the key factors for patient recovery. In this study, we focused on the relationship between MAP levels and 30-day mortality in patients with sepsis. Methods: This cohort study included 14,607 sepsis patients out of 38,597 adults admitted to Beth Israel Deaconess Medical Center in Boston between 2001 and 2012, according to the Sepsis 3.0 diagnostic criteria. According to the MAP value of the sepsis patients on the first day of intensive care unit (ICU) admission, they were divided into 5 groups (Q1 ≤67.4 mmHg, Q2 67.4-72.5 mmHg, Q3 72.5-77.6 mmHg, Q4 77.6-84.6 mmHg, Q5 ≥84.6 mmHg). At the same time, the baseline data of vital signs, critical illness score, comorbidities and laboratory examination were collected on the first day of admission to ICU. The 30-day mortality of the 5 groups of patients and the overall sepsis patients were recorded. Multivariate Cox regression analysis and smooth curve fitting were used to assess the independent association between MAP and 30-day mortality. Results: A total of 14,607 sepsis patients were screened. The mean age of participants was 67.2±16.3 years, approximately 46.9% were women, and the overall 30-day mortality rate was 21.0%. Multivariate Cox regression models and smooth curve fitting revealed a non-linear association between MAP and 30-day mortality. The inflection point occurred at 68.6 mmHg. The left side effect size of each 10-unit change in the exposure factor was [hazard ratio (HR): 0.479, 95% confidence interval (CI): 0.403-0.569, P<0.001]. To the right of the inflection point, the effect size was (HR: 0.996, 95% CI: 0.931-1.065, P<0.9018). Conclusions: Our study demonstrated a non-linear relationship between MAP and 30-day mortality in patients with sepsis. When MAP was less than 68.6 mmHg, it was a strong predictor of the potential risk of sepsis death, which declined by 52.1% for every 10 mmHg growth in MAP.
... In the tissue model, the arterioles present in the submocusa supposedly contribute to the pulsatile component of the PPG, whereas the submucosal venules, mucosa (containing the capillary network), and muscle contribute to the nonpulsatile component of PPG. 26 The arteriovenous blood volume ratio in the submucosa was 1:5. 27 In order to investigate the sensor-performance at different tissue physiologies, various states of tissue perfusion and oxygenation were simulated in a contact sensor-tissue reflectance geometry. The total submucosal blood volume was incremented from 2% to 10% through a step of 2% (in Table 1, the nominal submucosal blood volume of 4% is mentioned). ...
Article
Full-text available
Significance: Colorectal cancer is one of the major causes of cancer-related deaths worldwide. Surgical removal of the cancerous growth is the primary treatment for this disease. A colorectal cancer surgery, however, is often unsuccessful due to the anastomotic failure that may occur following the surgical incision. Prevention of an anastomotic failure requires continuous monitoring of intestinal tissue viability during and after colorectal surgery. To date, no clinical technology exists for the dynamic and continuous monitoring of the intestinal perfusion. Aim: A dual-wavelength indwelling bowel photoplethysmography (PPG) sensor for the continuous monitoring of intestinal viability was proposed and characterized through a set of in silico and in vivo investigations. Approach: The in silico investigation was based on a Monte Carlo model that was executed to quantify the variables such as penetration depth and detected intensity with respect to the sensor-tissue separations and tissue perfusion. Utilizing the simulated information, an indwelling reflectance PPG sensor was designed and tested on 20 healthy volunteers. Two sets of in vivo studies were performed using the driving current intensities 20 and 40 mA for a comparative analysis, using buccal tissue as a proxy tissue-site. Results: Both simulated and experimental results showed the efficacy of the sensor to acquire good signals through the "contact" to a "noncontact" separation of 5 mm. A very slow wavelength-dependent variation was shown in the detected intensity at the normal and hypoxic states of the tissue, whereas a decay in the intensity was found with the increasing submucosal-blood volume. The simulated detected-to-incident-photon-ratio and the experimental signal-to-noise ratio exhibited strong positive correlations, with the Pearson product-moment correlation coefficient R ranging between 0.65 and 0.87. Conclusions: The detailed feasibility analysis presented will lead to clinical trials utilizing the proposed sensor.
... If there is any change in compliance it will be on the venous side of the circulation, since arterial compliance, specifically related non-linearly to arterial blood pressure, is otherwise invariant. Suddenly, it occurred to me and David Green [1][2][3] that induction of anesthesia, was almost universally accompanied by a fall in arterial blood pressure and cardiac output with knowledge that there appeared to be a loss of circulating volume. The evidence for loss of volume was its improvement after an infusion of volume such as colloids or, with less persistent effect, crystalloids. ...
... Although the pulmonary circulation must, at all times, accept the entire cardiac output, vascular pressure in the lung is vastly lower than in the systemic circulation. This is accomplished by virtue of the construction of the vascular bed in the lung [25] as well as by active vasodilation resulting from the local synthesis and release of vasodilators including nitric oxide and PGI 2 [26,27]. In addition to the pulmonary vasculature itself, it is now recognized that circulating erythrocytes contribute to the low levels of vascular resistance present in the normal pulmonary circulation (5). ...
Article
Full-text available
The use of liposomes to affect targeted delivery of pharmaceutical agents to specific sites may result in the reduction of side effects and an increase in drug efficacy. Since liposomes are delivered intravascularly, erythrocytes, which constitute almost half of the volume of blood, are ideal targets for liposomal drug delivery. In vivo, erythrocytes serve not only in the role of oxygen transport but also as participants in the regulation of vascular diameter through the regulated release of the potent vasodilator, adenosine triphosphate (ATP). Unfortunately, erythrocytes of humans with pulmonary arterial hypertension (PAH) do not release ATP in response to the physiological stimulus of exposure to increases in mechanical deformation as would occur when these cells traverse the pulmonary circulation. This defect in erythrocyte physiology has been suggested to contribute to pulmonary hypertension in these individuals. In contrast to deformation, both healthy human and PAH erythrocytes do release ATP in response to incubation with prostacyclin analogs via a well-characterized signaling pathway. Importantly, inhibitors of phosphodiesterase 5 (PDE5) have been shown to significantly increase prostacyclin analog-induced ATP release from human erythrocytes. Here we investigate the hypothesis that targeted delivery of PDE5 inhibitors to human erythrocytes, using a liposomal delivery system, potentiates prostacyclin analog- induced ATP release. The findings are consistent with the hypothesis that directed delivery of this class of drugs to erythrocytes could be a new and important method to augment prostacyclin analog-induced ATP release from these cells. Such an approach could significantly limit side effects of both classes of drugs without compromising their therapeutic effectiveness in diseases such as PAH.
... Although the pulmonary circulation must, at all times, accept the entire cardiac output, vascular pressure in the lung is vastly lower than in the systemic circulation. This is accomplished by virtue of the construction of the vascular bed in the lung [25] as well as by active vasodilation resulting from the local synthesis and release of vasodilators including nitric oxide and PGI 2 [26,27]. In addition to the pulmonary vasculature itself, it is now recognized that circulating erythrocytes contribute to the low levels of vascular resistance present in the normal pulmonary circulation (5). ...
Article
Pulmonary arterial hypertension (PAH) is characterized by high pulmonary vascular resistance (PVR) and right heart failure. Red blood cells (RBCs) of PAH patients fail to release the vasodilator, adenosine triphosphate (ATP), when deformed as would occur when traversing the lung. Such a defect could contribute to increased PVR. However, RBCs of PAH patients do release ATP in response to prostacyclin (PGI2) analogs and this is augmented by phosphodiesterase 5 (PDE5) inhibitors. Current PAH treatment includes PGI2 analogs and PDE5 inhibitors alone or in combination. Unfortunately, these drugs can have untoward side effects. Encapsulation of drugs within liposomes (small lipid-membraned vesicles) that can be targeted to RBCs has been shown to increase effectiveness and tolerability of some medications. The objective of this study was to determine if encapsulation of the PDE5 inhibitor zaprinast (ZAP) within liposomes is an effective means to deliver this class of drugs to human RBCs and if this approach would augment ATP release stimulated by the PGI2 analog UT-15c. Human RBCs were isolated and incubated with either blank liposomes (n=10), liposomes containing ZAP (n=9) or liposomes containing the PDE3 inhibitor, cilosatzol (CILO, n=10). RBCs (20% hematocrit) were then treated with UT-15c (1 µM). ATP release was measured before and 5, 10, and 15 min after the addition of UT-15c. In the presence of empty liposomes, the dose of UT-15c used did not stimulate ATP release. However, UT-15c did stimulate ATP release from RBCs pretreated with ZAP encapsulated by liposomes (P<0.01). The average time for maximal release was 9 ± 1 min. In contrast, when exposed to liposomes containing CILO, there was no ATP release following UT-15c administration. These studies demonstrate that the selective delivery of a PDE5 inhibitor to human RBCs potentiates UT-15c induced ATP release. Moreover the findings are consistent with the hypothesis that directed delivery of this class of drugs to PAH RBCs could be a new and important method to augment PGI2 analog-induced ATP release from these cells. Such an approach could significantly limit side effects of both drugs without compromise of their therapeutic effectiveness in PAH. Disclosures No relevant conflicts of interest to declare.
Chapter
The number of high-risk patients undergoing surgery is growing. To maintain adequate hemodynamic conditions as well as oxygen delivery to the vital organs (DO2) among this patient population, a rapid assessment of cardiac function is essential. In this context, hemodynamic focused echocardiography offers an excellent opportunity to examine the signs of cardiac filling impairment, preload, myocardial contractility, and the function of the heart valves. In this chapter, a practical six-step approach towards a perioperative echocardiographic-based hemodynamic optimization is presented. The summary of all echocardiographic findings and their integration in the clinical context along with the patients’ medical background allows a differentiated assessment of the patient’s cardiovascular function and can thus help guide a (patho)physiological-orientated and individualized hemodynamic therapy.